Scientists at Albert Einstein College of Medicine have discovered the first compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach, described in today’s issue of Cancer Cell, was directed against acute myeloid leukemia (AML) cells but may also have potential for attacking other types of cancers.
“We’re hopeful that the targeted compounds we’re developing will prove more effective than current anti-cancer therapies by directly causing cancer cells to self-destruct,” says Evripidis Gavathiotis, Ph.D., associate professor of biochemistry and of medicine and senior author of the study. “Ideally, our compounds would be combined with other treatments to kill cancer cells faster and more efficiently—and with fewer adverse effects, which are an all-too-common problem with standard chemotherapies.”
AML accounts for nearly one-third of all new leukemia cases and kills more than 10,000 Americans each year. The survival rate for patients has remained at about 30 percent for several decades, so better treatments are urgently needed.
The newly discovered compound combats cancer by triggering apoptosis—an important process that rids the body of unwanted or malfunctioning cells. Apoptosis trims excess tissue during embryonic development, for example, and some chemotherapy drugs indirectly induce apoptosis by damaging DNA in cancer cells.
Apoptosis occurs when BAX—the “executioner protein” in cells—is activated by “pro-apoptotic” proteins in the cell. Once activated, BAX molecules home in on and punch lethal holes in mitochondria, the parts of cells that produce energy. But all too often, cancer cells manage to prevent BAX from killing them. They ensure their survival by producing copious amounts of “anti-apoptotic” proteins that suppress BAX and the proteins that activate it.
“Our novel compound revives suppressed BAX molecules in cancer cells by binding with high affinity to BAX’s activation site,” says Dr. Gavathiotis. “BAX can then swing into action, killing cancer cells while leaving healthy cells unscathed.”
Dr. Gavathiotis was the lead author of a 2008 paper in Nature that first described the structure and shape of BAX’s activation site. He has since looked for small molecules that can activate BAX strongly enough to overcome cancer cells’ resistance to apoptosis. His team initially used computers to screen more than one million compounds to reveal those with BAX-binding potential. The most promising 500 compounds—many of them newly synthesized by Dr. Gavathiotis’ team—were then evaluated in the laboratory.
“A compound dubbed BTSA1 (short for BAX Trigger Site Activator 1) proved to be the most potent BAX activator, causing rapid and extensive apoptosis when added to several different human AML cell lines,” says lead author Denis Reyna, M.S., a doctoral student in Dr. Gavathiotis’ lab. The researchers next tested BTSA1 in blood samples from patients with high-risk AML. Strikingly, BTSA1 induced apoptosis in the patients’ AML cells but did not affect patients’ healthy blood-forming stem cells.
Finally, the researchers generated animal models of AML by grafting human AML cells into mice. BTSA1 was given to half the AML mice while the other half served as controls. On average, the BTSA1-treated mice survived significantly longer (55 days) than the control mice (40 days), with 43 percent of BTSA1-treated AML mice alive after 60 days and showing no signs of AML.
Importantly, the mice treated with BTSA1 showed no evidence of toxicity. “BTSA1 activates BAX and causes apoptosis in AML cells while sparing healthy cells and tissues—probably because the cancer cells are primed for apoptosis,” says Dr. Gavathiotis. He notes that his study found that AML cells from patients contained significantly higher BAX levels compared with normal blood cells from healthy people. “With more BAX available in AML cells,” he explained, “even low BTSA1 doses will trigger enough BAX activation to cause apoptotic death, while sparing healthy cells that contain low levels of BAX or none at all.”
Plans call for Dr. Gavathiotis and his team to see whether BTSA1 will show similar effectiveness when tested on animal models of other types of cancer.
The Latest on: Cancer cells commit suicide
Science Surgery: ‘Do we all have potentially cancerous cells in our bodies?’
on April 18, 2018 at 12:00 am
... further checks in place to stop the damaged cell from dividing and potentially leading to a cancer. For example, the cell can be forced to commit suicide so that it can’t pass on its faulty DNA to new cells. But even then, on rare occasions, some ... […]
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
on April 16, 2018 at 11:04 am
Some of these tumors’ roadblocks include cancer cells sneakily masking themselves from recognition by engineered immune cells or sending out signals that cause the therapeutic T cells to commit suicide before they can do their job. As compared to blood ... […]
Companies claim marijuana makes cancer “commit suicide,” FDA loses it
on November 3, 2017 at 3:00 am
“Combats tumor and cancer cells” “makes cancer cells commit ‘suicide’ without killing other cells” “[has] anti-proliferative properties that inhibit cell division and growth in certain types of cancer, not allowing the tumor to grow” “may ... […]
'Suicide molecule' could lead to fail-safe cancer therapy, scientists say
on October 20, 2017 at 8:00 am
A "suicide molecule" that forces tumours to self-destruct could open the door to fail-safe cancer therapy, scientists ... safe that forces rogue cells to commit suicide. "We believe it is active in every cell protecting us from cancer." […]
Suicide molecules kill any cancer cell
on October 18, 2017 at 5:00 pm
The mechanism—RNA suicide molecules—can potentially be developed ... "It could be a fail safe that forces rogue cells to commit suicide. We believe it is active in every cell protecting us from cancer." This study, which will be published Oct. 24 ... […]
New compound can make cancer cells commit suicide
on October 10, 2017 at 1:19 am
Researchers say that this compound can be very useful for a country like India, which is seeing a growth in cancer cases. Washington: A group of researchers has found a compound which can kill cancer cells without harming the healthy cells present in our ... […]
Novel therapy drives cancer cells to commit suicide
on October 9, 2017 at 11:40 pm
New York, Oct 10 (IANS) Scientists have discovered a compound that directly makes cancer cells commit suicide while sparing healthy cells, paving the way for a more effective cancer treatment with fewer adverse effects. "We're hopeful that the targeted ... […]
Cancer commits suicide 'in just 2 hours'
on July 4, 2016 at 1:21 pm
(THE SUN) — Cancer cells in lab mice were found to self-destruct ... “The one thing they have in common is their susceptibility to this induced cell suicide. […]
Zapping Cancer Tumours Triggers 'Cell Suicide'
on July 3, 2016 at 5:00 pm
Injecting cancerous tumours with a chemical then zapping them with a flash of light can cause them to commit "cell ... has been shown to cause cancer cells to effectively self-destruct in fewer than 120 minutes. The "cell suicide" happens because they ... […]
Magnetic Nanoparticles Target Tumors and Get Cells to Commit Suicide
on August 22, 2014 at 6:20 am
the liver tumor promoter gene “drives” the nanoparticle to the liver cancer cells and then the suicide gene causes the cancer cells to commit suicide. These nanoparticles were about 20 nm wide, do not provoke an immune system response and they can be ... […]
via Google News and Bing News